Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease

NCT01689233 is registered in ClinicalTrials.gov with TauRx Therapeutics Ltd as lead sponsor.

NCT NCT01689233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01689233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Lead sponsor
TauRx Therapeutics Ltd
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2012
Completion date
May 31, 2016
Enrollment
800 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease